Skip to main content
Top
Published in: Journal of Gastroenterology 4/2013

01-04-2013 | Original Article—Liver, Pancreas, and Biliary Tract

The role of peroral video cholangioscopy in patients with IgG4-related sclerosing cholangitis

Authors: Takao Itoi, Terumi Kamisawa, Yoshinori Igarashi, Hiroshi Kawakami, Ichiro Yasuda, Fumihide Itokawa, Yuui Kishimoto, Masaki Kuwatani, Shinpei Doi, Seiichi Hara, Fuminori Moriyasu, Todd H. Baron

Published in: Journal of Gastroenterology | Issue 4/2013

Login to get access

Abstract

Background

The cholangioscopic features of IgG4-related sclerosing cholangitis (IgG4-SC) remain undefined. The aim of this study was to clarify these endoscopic features using peroral video cholangioscopy (PVCS) in IgG4-SC patients.

Methods

PVCS was performed in 33 patients: IgG4-SC (n = 13); primary sclerosing cholangitis (PSC; n = 5); and cholangiocarcinoma (n = 15), which included hilar cholangiocarcinoma (HCCA; n = 5) and distal cholangiocarcinoma (DCCA; n = 10).

Results

The most frequent findings on PVCS in the IgG4-SC patients were dilated (62 %) and tortuous (69 %) vessels, and absence of partially enlarged vessels. The incidence of dilated and tortuous vessels was significantly higher in IgG4-SC patients than in PSC patients (p = 0.015). Scarring and pseudodiverticula were found significantly more often in PSC patients than in IgG4-SC patients (p = 0.001 and p = 0.0007, respectively). The incidence of partially enlarged vessels was significantly higher in DCCA patients than in IgG4-SC patients (p = 0.004). In contrast, the incidence of dilated vessels was significantly higher in IgG4-SC patients than in HCCA patients (p = 0.015). PVCS performed after corticosteroid therapy showed resolution of bile duct stenosis and dilated, tortuous, or partially enlarged vessels, as well as resolution of friability in all patients with IgG4-SC.

Conclusion

Cholangioscopy was useful in differentiating IgG4-SC from PSC. In addition, monitoring the patterns of proliferative vessels on PVCS may be useful to differentiate IgG4-SC from cholangiocarcinoma.
Literature
1.
go back to reference Umehara H, Okazaki K, Masaki Y, Kawano M, Yamamoto M, Saeki T. Comprehensive diagnostic criteria for IgG4-related disease (IgG4-RD), 2011. Mod Rheumatol. 2012;22:21–30.PubMedCrossRef Umehara H, Okazaki K, Masaki Y, Kawano M, Yamamoto M, Saeki T. Comprehensive diagnostic criteria for IgG4-related disease (IgG4-RD), 2011. Mod Rheumatol. 2012;22:21–30.PubMedCrossRef
2.
go back to reference Kamisawa T, Takuma K, Egawa N, Tsuruta K, Sasaki T. Autoimmune pancreatitis and IgG4-related sclerosing disease. Nat Rev Gastroenterol Hepatol. 2010;7:401–9.PubMedCrossRef Kamisawa T, Takuma K, Egawa N, Tsuruta K, Sasaki T. Autoimmune pancreatitis and IgG4-related sclerosing disease. Nat Rev Gastroenterol Hepatol. 2010;7:401–9.PubMedCrossRef
3.
go back to reference The Research Committee of IgG4-related Diseases provided by the Ministry of Health, Labor and Welfare of Japan: The Research Committee of Intractable Diseases of Liver and Biliary Tract provided by the Ministry of Health, Labor and Welfare of Japan: The Japan Biliary Association. Clinical diagnostic criteria of IgG4-related sclerosing cholangitis 2012 (Japanese with English abstract). J Jpn Bil Assoc. 2012;26:59–63. The Research Committee of IgG4-related Diseases provided by the Ministry of Health, Labor and Welfare of Japan: The Research Committee of Intractable Diseases of Liver and Biliary Tract provided by the Ministry of Health, Labor and Welfare of Japan: The Japan Biliary Association. Clinical diagnostic criteria of IgG4-related sclerosing cholangitis 2012 (Japanese with English abstract). J Jpn Bil Assoc. 2012;26:59–63.
4.
go back to reference Zen Y, Harada K, Sasaki M, Sato Y, Tsuneyama K, Haratake J. IgG4-related sclerosing cholangitis with and without hepatic inflammatory pseudotumor, and sclerosing pancreatitis-associated sclerosing cholangitis: do they belong to a spectrum of sclerosing pancreatitis? Am J Surg Pathol. 2004;28:1193–203.PubMedCrossRef Zen Y, Harada K, Sasaki M, Sato Y, Tsuneyama K, Haratake J. IgG4-related sclerosing cholangitis with and without hepatic inflammatory pseudotumor, and sclerosing pancreatitis-associated sclerosing cholangitis: do they belong to a spectrum of sclerosing pancreatitis? Am J Surg Pathol. 2004;28:1193–203.PubMedCrossRef
5.
go back to reference Ghazale A, Chari ST, Zhang L, Smyrk TC, Takahashi N, Levy MJ. Immunoglobulin G4-associated cholangitis: clinical profile and response to therapy. Gastroenterology. 2008;134:706–15.PubMedCrossRef Ghazale A, Chari ST, Zhang L, Smyrk TC, Takahashi N, Levy MJ. Immunoglobulin G4-associated cholangitis: clinical profile and response to therapy. Gastroenterology. 2008;134:706–15.PubMedCrossRef
6.
go back to reference Kamisawa T, Tabata T. IgG4-related sclerosing cholangitis. Ann Hepatol. 2011;10:552–5.PubMed Kamisawa T, Tabata T. IgG4-related sclerosing cholangitis. Ann Hepatol. 2011;10:552–5.PubMed
7.
go back to reference Nakazawa T, Ohara H, Sano H, Ando T, Aoki S, Kobayashi S. Clinical differences between primary sclerosing cholangitis and sclerosing cholangitis with autoimmune pancreatitis. Pancreas. 2005;30:20–5.PubMed Nakazawa T, Ohara H, Sano H, Ando T, Aoki S, Kobayashi S. Clinical differences between primary sclerosing cholangitis and sclerosing cholangitis with autoimmune pancreatitis. Pancreas. 2005;30:20–5.PubMed
8.
go back to reference LaRusso NF, Wiesner RH, Ludwig J, MacCarty RL. Current concepts. Primary sclerosing cholangitis. N Engl J Med. 1984;310:899–903.PubMedCrossRef LaRusso NF, Wiesner RH, Ludwig J, MacCarty RL. Current concepts. Primary sclerosing cholangitis. N Engl J Med. 1984;310:899–903.PubMedCrossRef
9.
go back to reference Wiesner RH, Grambsch PM, Dickson ER, Ludwig J, MacCarty RL, Hunter EB. Primary sclerosing cholangitis: natural history, prognostic factor and survival analysis. Hepatology. 1989;10:430–6.PubMedCrossRef Wiesner RH, Grambsch PM, Dickson ER, Ludwig J, MacCarty RL, Hunter EB. Primary sclerosing cholangitis: natural history, prognostic factor and survival analysis. Hepatology. 1989;10:430–6.PubMedCrossRef
10.
go back to reference Hamano H, Kawa S, Uehara T, Ochi Y, Takayama M, Komatsu K. Immunoglobulin G4-related lymphoplasmacytic sclerosing cholangitis that mimics infiltrating hilar cholangiocarcinoma: part of a spectrum of autoimmune pancreatitis? Gastrointest Endosc. 2005;62:152–7.PubMedCrossRef Hamano H, Kawa S, Uehara T, Ochi Y, Takayama M, Komatsu K. Immunoglobulin G4-related lymphoplasmacytic sclerosing cholangitis that mimics infiltrating hilar cholangiocarcinoma: part of a spectrum of autoimmune pancreatitis? Gastrointest Endosc. 2005;62:152–7.PubMedCrossRef
11.
go back to reference Weber A, von Weyhern C, Fend F, et al. Endoscopic transpapillary brush cytology and forceps biopsy in patients with hilar cholangiocarcinoma. World J Gastroenterol. 2008;14:1097–101.PubMedCrossRef Weber A, von Weyhern C, Fend F, et al. Endoscopic transpapillary brush cytology and forceps biopsy in patients with hilar cholangiocarcinoma. World J Gastroenterol. 2008;14:1097–101.PubMedCrossRef
12.
go back to reference Farrell RJ, Jain AK, Brandwein SL, et al. The combination of stricture dilation, endoscopic needle aspiration, and biliary brushings significantly improves diagnostic yield from malignant bile duct strictures. Gastrointest Endosc. 2001;54:587–94.PubMedCrossRef Farrell RJ, Jain AK, Brandwein SL, et al. The combination of stricture dilation, endoscopic needle aspiration, and biliary brushings significantly improves diagnostic yield from malignant bile duct strictures. Gastrointest Endosc. 2001;54:587–94.PubMedCrossRef
13.
go back to reference Nakajima M, Akasaka Y, Fukumoto K, et al. Peroral cholangiopancreatoscopy (PCPS) under duodenoscopic guidance. Am J Gastroenterol. 1978;66:241–7. Nakajima M, Akasaka Y, Fukumoto K, et al. Peroral cholangiopancreatoscopy (PCPS) under duodenoscopic guidance. Am J Gastroenterol. 1978;66:241–7.
14.
go back to reference Kozarek R. Direct cholangioscopy and pancreatoscopy at time of endoscopic retrograde cholangiopancreatography. Am J Gastroentrol. 1988;83:55–7. Kozarek R. Direct cholangioscopy and pancreatoscopy at time of endoscopic retrograde cholangiopancreatography. Am J Gastroentrol. 1988;83:55–7.
15.
go back to reference Fukuda Y, Tsuyuguchi T, Sakai Y, et al. Diagnostic utility of peroral cholangioscopy for various bile-duct lesions. Gastrointest Endosc. 2005;62:374–82.PubMedCrossRef Fukuda Y, Tsuyuguchi T, Sakai Y, et al. Diagnostic utility of peroral cholangioscopy for various bile-duct lesions. Gastrointest Endosc. 2005;62:374–82.PubMedCrossRef
16.
go back to reference Shah RJ, Langer DA, Antillon MR, Chen YK. Cholangioscopy and cholangioscopic forceps biopsy in patients with indeterminate pancreaticobiliary pathology. Clin Gastroenterol Hepatol. 2006;4:219–25.PubMedCrossRef Shah RJ, Langer DA, Antillon MR, Chen YK. Cholangioscopy and cholangioscopic forceps biopsy in patients with indeterminate pancreaticobiliary pathology. Clin Gastroenterol Hepatol. 2006;4:219–25.PubMedCrossRef
17.
go back to reference Awadallah NS, Chen YK, Piraka C, et al. Is there a role for cholangioscopy in patients with primary sclerosing cholangitis? Am J Gastroenterol. 2006;101:284–91.PubMedCrossRef Awadallah NS, Chen YK, Piraka C, et al. Is there a role for cholangioscopy in patients with primary sclerosing cholangitis? Am J Gastroenterol. 2006;101:284–91.PubMedCrossRef
18.
go back to reference Itoi T, Sofuni A, Itokawa F, et al. Peroral cholangioscopic diagnosis of biliary tract diseases using narrow-band imaging. Gastrointest Endosc. 2007;66:730–6.PubMedCrossRef Itoi T, Sofuni A, Itokawa F, et al. Peroral cholangioscopic diagnosis of biliary tract diseases using narrow-band imaging. Gastrointest Endosc. 2007;66:730–6.PubMedCrossRef
19.
go back to reference Itoi T, Osanai M, Igarashi Y, et al. Diagnostic peroral video cholangioscopy is an accurate diagnostic tool for patients with bile-duct lesions. Clin Gastroenterol Hepatol. 2010;8:934–8.PubMedCrossRef Itoi T, Osanai M, Igarashi Y, et al. Diagnostic peroral video cholangioscopy is an accurate diagnostic tool for patients with bile-duct lesions. Clin Gastroenterol Hepatol. 2010;8:934–8.PubMedCrossRef
20.
go back to reference Kawakami H, Kuwatani M, Etoh K, et al. Endoscopic retrograde cholangiography versus peroral cholangioscopy to evaluate intraepithelial tumor spread in biliary cancer. Endoscopy. 2009;41:959–64.PubMedCrossRef Kawakami H, Kuwatani M, Etoh K, et al. Endoscopic retrograde cholangiography versus peroral cholangioscopy to evaluate intraepithelial tumor spread in biliary cancer. Endoscopy. 2009;41:959–64.PubMedCrossRef
21.
go back to reference Itoi T, Neuhaus H, Chen YK. Diagnostic value of imaging-enhanced video cholangiopancreatoscopy. Gastrointest Endosc Clin N Am. 2009;19:557–66.PubMedCrossRef Itoi T, Neuhaus H, Chen YK. Diagnostic value of imaging-enhanced video cholangiopancreatoscopy. Gastrointest Endosc Clin N Am. 2009;19:557–66.PubMedCrossRef
22.
go back to reference Yasuda I, Nakashima M, Moriwaki H. Cholangioscopic view of IgG4-related sclerosing cholangitis. J Hepatobiliary Pancreat Sci. 2011;18:122–4.PubMedCrossRef Yasuda I, Nakashima M, Moriwaki H. Cholangioscopic view of IgG4-related sclerosing cholangitis. J Hepatobiliary Pancreat Sci. 2011;18:122–4.PubMedCrossRef
23.
go back to reference Shimosegawa T, Chari ST, Frulloni L, et al. International consensus diagnostic criteria for autoimmune pancreatitis: guidelines of the International Association of Pancreatology. Pancreas. 2011;40:352–8.PubMedCrossRef Shimosegawa T, Chari ST, Frulloni L, et al. International consensus diagnostic criteria for autoimmune pancreatitis: guidelines of the International Association of Pancreatology. Pancreas. 2011;40:352–8.PubMedCrossRef
24.
go back to reference Graziadei IW, Wiesner RH, Batts KP, et al. Recurrence of primary sclerosing cholangitis following liver transplantation. Hepatology. 1999;29:1050–6.PubMedCrossRef Graziadei IW, Wiesner RH, Batts KP, et al. Recurrence of primary sclerosing cholangitis following liver transplantation. Hepatology. 1999;29:1050–6.PubMedCrossRef
25.
26.
go back to reference Nakazawa T, Ohara H, Sano H, et al. Cholangiography can discriminate sclerosing cholangitis with autoimmune pancreatitis from primary sclerosing cholangitis. Gastrointest Endosc. 2004;60:937–44.PubMedCrossRef Nakazawa T, Ohara H, Sano H, et al. Cholangiography can discriminate sclerosing cholangitis with autoimmune pancreatitis from primary sclerosing cholangitis. Gastrointest Endosc. 2004;60:937–44.PubMedCrossRef
27.
go back to reference Mendes FD, Jorgensen R, Keach J, et al. Elevated serum IgG4 concentration in patients with primary sclerosing cholangitis. Am J Gastroenterol. 2006;101:2070–5.PubMedCrossRef Mendes FD, Jorgensen R, Keach J, et al. Elevated serum IgG4 concentration in patients with primary sclerosing cholangitis. Am J Gastroenterol. 2006;101:2070–5.PubMedCrossRef
28.
go back to reference Tischendorf JJW, Kruger M, Trautwein C, et al. Cholangioscopic characterization of dominant bile duct stenosis in patients with primary sclerosing cholangitis. Endoscopy. 2006;38:665–9.PubMedCrossRef Tischendorf JJW, Kruger M, Trautwein C, et al. Cholangioscopic characterization of dominant bile duct stenosis in patients with primary sclerosing cholangitis. Endoscopy. 2006;38:665–9.PubMedCrossRef
29.
go back to reference Katabi N, Albores-Saavedra J. The extrahepatic bile duct lesions in end-stage primary sclerosing cholangitis. Am J Surg Pathol. 2003;27:349–55.PubMedCrossRef Katabi N, Albores-Saavedra J. The extrahepatic bile duct lesions in end-stage primary sclerosing cholangitis. Am J Surg Pathol. 2003;27:349–55.PubMedCrossRef
30.
go back to reference Kasuya K, Watanabe H, Itoi T, et al. Histological grading of malignancy of extrahepatic bile duct carcinomas (Japanese with English abstract). Stomach Intestine. 1994;29:751–9. Kasuya K, Watanabe H, Itoi T, et al. Histological grading of malignancy of extrahepatic bile duct carcinomas (Japanese with English abstract). Stomach Intestine. 1994;29:751–9.
31.
go back to reference Kalaitzakis E, Levy M, Kamisawa T, et al. Endoscopic retrograde cholangiography does not reliably distinguish IgG4-associated cholangitis from primary sclerosing cholangitis or cholangiocarcinoma. Clin Gastroenterol Hepatol. 2011;9:800–3.PubMedCrossRef Kalaitzakis E, Levy M, Kamisawa T, et al. Endoscopic retrograde cholangiography does not reliably distinguish IgG4-associated cholangitis from primary sclerosing cholangitis or cholangiocarcinoma. Clin Gastroenterol Hepatol. 2011;9:800–3.PubMedCrossRef
32.
go back to reference Itokawa F, Itoi T, Sofuni A. Peroral videocholangioscopy using narrow band imaging for early bile duct cancer (with video). J Hepatobiliary Pancreat Surg. 2010;17:731–2.CrossRef Itokawa F, Itoi T, Sofuni A. Peroral videocholangioscopy using narrow band imaging for early bile duct cancer (with video). J Hepatobiliary Pancreat Surg. 2010;17:731–2.CrossRef
33.
go back to reference Weber A, Schmid RM, Prinz C. Diagnostic approaches for cholangiocarcinoma. World J Gastroenterol. 2008;14:4131–6.PubMedCrossRef Weber A, Schmid RM, Prinz C. Diagnostic approaches for cholangiocarcinoma. World J Gastroenterol. 2008;14:4131–6.PubMedCrossRef
34.
go back to reference Kawakami H, Zen Y, Kuwatani M, et al. IgG4-related sclerosing cholangitis and autoimmune pancreatitis: histological assessment of biopsies from Vater’s ampulla and the bile duct. J Gastroenterol Hepatol. 2010;25:1648–55.PubMedCrossRef Kawakami H, Zen Y, Kuwatani M, et al. IgG4-related sclerosing cholangitis and autoimmune pancreatitis: histological assessment of biopsies from Vater’s ampulla and the bile duct. J Gastroenterol Hepatol. 2010;25:1648–55.PubMedCrossRef
Metadata
Title
The role of peroral video cholangioscopy in patients with IgG4-related sclerosing cholangitis
Authors
Takao Itoi
Terumi Kamisawa
Yoshinori Igarashi
Hiroshi Kawakami
Ichiro Yasuda
Fumihide Itokawa
Yuui Kishimoto
Masaki Kuwatani
Shinpei Doi
Seiichi Hara
Fuminori Moriyasu
Todd H. Baron
Publication date
01-04-2013
Publisher
Springer Japan
Published in
Journal of Gastroenterology / Issue 4/2013
Print ISSN: 0944-1174
Electronic ISSN: 1435-5922
DOI
https://doi.org/10.1007/s00535-012-0652-6

Other articles of this Issue 4/2013

Journal of Gastroenterology 4/2013 Go to the issue
Live Webinar | 27-06-2024 | 18:00 (CEST)

Keynote webinar | Spotlight on medication adherence

Live: Thursday 27th June 2024, 18:00-19:30 (CEST)

WHO estimates that half of all patients worldwide are non-adherent to their prescribed medication. The consequences of poor adherence can be catastrophic, on both the individual and population level.

Join our expert panel to discover why you need to understand the drivers of non-adherence in your patients, and how you can optimize medication adherence in your clinics to drastically improve patient outcomes.

Prof. Kevin Dolgin
Prof. Florian Limbourg
Prof. Anoop Chauhan
Developed by: Springer Medicine
Obesity Clinical Trial Summary

At a glance: The STEP trials

A round-up of the STEP phase 3 clinical trials evaluating semaglutide for weight loss in people with overweight or obesity.

Developed by: Springer Medicine